De Smedt, J.; KU Leuven Laboratory of Dermatology, Department of oncology, Leuven, Belgium, University Hospitals Leuven, Department of Dermatology, Leuven, Belgium
Van Kelst, Sofie; KU Leuven Laboratory of Dermatology, Department of oncology, Leuven, Belgium, University Hospitals Leuven, Department of Dermatology, Leuven, Belgium
Boecxstaens, Veerle; University Hospitals Leuven, Oncological and vascular access surgery, Department of surgical oncology, Leuven, Belgium, KU Leuven, Department of oncology, Leuven, Belgium
Stas, Marguerite; University Hospitals Leuven, Oncological and vascular access surgery, Department of surgical oncology, Leuven, Belgium, KU Leuven, Department of oncology, Leuven, Belgium
Bogaerts, Kris; KU Leuven, Faculty of Medicine, I-BioStat, Leuven, Belgium, Hasselt University, I-BioStat, Diepenbeek, Belgium
Vanderschueren, Dirk; KU Leuven Clinical and Experimental Endocrinology, Department of Clinical and Experimental Medicine, Leuven, Belgium, University Hospitals Leuven, Department of Endocrinology, Leuven, Belgium
Aura, Claudia; KU Leuven Translational Cell and Tissue Research, Department of Imaging and Pathology, Leuven, Belgium, University Hospitals of Leuven, Department of Pathology, Leuven, Belgium
Vanden Berghe, Katleen
Lambrechts, Diether; KU Leuven Laboratory for Translational Genetics, Department of Oncology, Leuven, Belgium, Vesalius Research Center, VIB, Leuven, Belgium
Wolter, Pascal; CHR Verviers East Belgium, Department of Hematology and Oncology, Verviers, Belgium
Bechter, Oliver E.; KU Leuven Laboratory of Experimental Oncology (LEO), Department of Oncology, Leuven, Belgium, University Hospitals Leuven, Leuven Cancer Institute, Department of General Medical Oncology, Leuven, Belgium
Nikkels, Arjen ; Université de Liège - ULiège > Département des sciences cliniques > Dermatologie
Strobbe, Tine; University Hospital Antwerp, Department of Dermatology, Edegem, Belgium
Emri, Gabriella; University of Debrecen, Department of Dermatology, Faculty of Medicine, Debrecen, Hungary
Marasigan, Vivien; KU Leuven Laboratory of Dermatology, Department of oncology, Leuven, Belgium, University Hospitals Leuven, Department of Dermatology, Leuven, Belgium
Garmyn, Marjan A.; KU Leuven Laboratory of Dermatology, Department of oncology, Leuven, Belgium, University Hospitals Leuven, Department of Dermatology, Leuven, Belgium
Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): A randomized controlled trial
Publication date :
2017
Journal title :
BMC Cancer
eISSN :
1471-2407
Publisher :
BioMed Central Ltd., United Kingdom
Volume :
17
Issue :
1
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
KU Leuven - Katholieke Universiteit Leuven [BE] University of Miami Cambridge University Hospitals Glenn Research Center Marie Curie Cancer Care Korean Academy of Medical Sciences Chrysalis Centre Hospitalier Universitaire de Québec
Belgian Cancer Registry: De tien meest frequente tumoren per geslacht, België 2013. http://www.kankerregister.org/statistieken.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med. 2006;355(1):51-65.
Doe J. Incidence fact sheet malignant melanoma. In: Belgian Cancer Registry incidence fact sheets. 2013. http://www.kankerregister.org/media/docs/Incidencefactsheets/Incidence:Fact_Sheet_MalignantMelanoma_2013.pdf. Accessed 22 Sept 2015.
Marks R. Epidemiology of melanoma. Clin Exp Dermatol. 2000;25:459-63.
Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27:3-9.
Bataille V, de Vries E. Melanoma part 1: epidemiology, risk factors, and prevention. BMJ. 2008; doi: 10.1136/bmj.a2249.
Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95(11):806-12.
Newton-Bishop JA, Beswick S, Randerson-Moor J, Chang YM, Affleck P, Elliott F, Chan M, Leake S, Karpavicius B, Haynes S, Kukalizch K, Whitaker L, Jackson S, Gerry E, Nolan C, Bertram C, Marsden J, Elder DE, Barrett JH, Bishop DT. Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J Clin Onc. 2009;27(32):5439-44.
Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199-206.
Field S, Newton-Bishop JA. Melanoma and vitamin D. Mol Oncol. 2011;5:197-214.
Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol. 2002;147:197-213.
Egan KM. Vitamin D and melanoma. Ann Epidemiol 2009; 19 (7): 455-461.
Sage RJ, Lim HW. Therapeutic hotline: recommendations on photoprotection and vitamin D. Dermatol Ther. 2010;23(1):82-5.
Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, Peltonen L, Cooper JD, O'Reilly PF, Houston DK, Glazer NL, Vandenput L, Peacock M, Shi J, Rivadeneira F, MI MC, Anneli P, de Boer IH, Mangino M, Kato B, Smyth DJ, Booth SL, Jacques PF, Burke GL, Goodarzi M, Cheung CL, Wolf M, Rice K, Goltzman D, Hidiroglou N, Ladouceur M, Wareham NJ, Hocking LJ, Hart D, Arden NK, Cooper C, Malik S, Fraser WD, Hartikainen AL, Zhai G, Macdonald HM, Forouhi NG, Loos RJ, Reid DM, Hakim A, Dennison E, Liu Y, Power C, Stevens HE, Jaana L, Vasan RS, Soranzo N, Bojunga J, Psaty BM, Lorentzon M, Foroud T, Harris TB, Hofman A, Jansson JO, Cauley JA, Uitterlinden AG, Gibson Q, Järvelin MR, Karasik D, Siscovick DS, Econs MJ, Kritchevsky SB, Florez JC, Todd JA, Dupuis J, Hyppönen E, Spector TD. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180-8.
Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, Van Eldere J, Decallone B, Bouilon R, Decramer M, Janssens W. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2012;156(2):105-14.
Saw RPM, Armstrong BK, Mason RS, Morton RL, Shannon KF, Spillane AJ, Stretch JR, Thompson JF. Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomized phase II trial (ANZMTG 0.09 Mel-D). BMC Cancer. 2014;14:780.
Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood). 2010;235(9):1034-45.
Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204-10.
Colston K. Colston Mj, feldman D. 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology. 1981;108(3):1083-6.
Caini S, Boniol M, Tosti G, Magi S, Medri M, Stanganelli I, Palli D, Assedi M, Del Marmol V, Gandini S. Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and metanalysis. Eur J Cancer. 2014;50(15):2649-58.
Eisman JA, Barkla DH, Tutton PJM. Suppression of in vivo growth of human cancer solid tumor Xenografts by 1,25-Dihydroxyvitamin D3. Cancer Res. 1987;47:21-5.
Saiag P, Aegerter P, Vitoux D, Lebbé C, Wolkenstein P, Dupin N, Descamps V, Aractingi S, Funck-Brentano E, Autier P, Dragomir M, Boniol M. Prognostic value of 25-hydroxyvitamin D3 levels at diagnosis and during follow-up in melanoma patients. JNCI J Natl Canc Inst. 2015;107(12):djv264.
Fang S, Sui D, Wang Y, Liu H, Chiang Y-J, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Wargo J, Hu MI, Gardner JM, Reveille JD, Bassett RL, Wei Q, Amos CI, Lee J. Association of Vitamin D levels with outcome in patients with melanoma after adjustment for C-reactive protein. J Clinical Oncol. 2016;34(19):1741-7.